Met Life Investment Management, LLC Axsome Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 22,277 shares of AXSM stock, worth $2.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,277

Previous 21,045 5.85%

Holding current value

$2.31 Million

Previous $1.89 Million 0.32%

% of portfolio

0.01%

Previous 0.01%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$83.08 - $100.49 $102,354 - $123,803	1,232 Added 5.85%	22,277 $1.88 Million
Q2 2024 Aug 13, 2024	BUY	$65.72 - $80.5 $167,060 - $204,631	2,542 Added 13.74%	21,045 $1.69 Million
Q1 2024 May 14, 2024	BUY	$69.39 - $97.64 $1.28 Million - $1.81 Million	18,503 New	18,503 $1.48 Million
Q3 2023 May 09, 2024	BUY	$69.25 - $82.21 $111,007 - $131,782	1,603 Added 9.49%	18,503 $1.29 Million
Q3 2023 Apr 29, 2024	BUY	$69.25 - $82.21 $88,778 - $105,393	1,282 Added 7.44%	18,503 $1.29 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $88,778 - $105,393	1,282 Added 7.44%	18,503 $1.29 Million
Q2 2023 Apr 29, 2024	BUY	$58.41 - $90.35 $1.01 Million - $1.56 Million	17,221 New	17,221 $1.24 Million
Q2 2023 Aug 10, 2023	BUY	$58.41 - $90.35 $18,749 - $29,002	321 Added 1.9%	17,221 $1.24 Million
Q1 2023 May 09, 2024	BUY	$58.39 - $75.0 $986,791 - $1.27 Million	16,900 New	16,900 $1.04 Billion
Q4 2022 May 10, 2024	BUY	$39.94 - $79.72 $22,286 - $44,483	558 Added 3.41%	16,900 $1.3 Million
Q4 2022 Mar 22, 2023	BUY	$39.94 - $79.72 $22,286 - $44,483	558 Added 3.41%	16,900 $1.3 Million
Q4 2022 Feb 15, 2023	BUY	$39.94 - $79.72 $22,286 - $44,483	558 Added 3.41%	16,900 $1.3 Million
Q3 2022 May 10, 2024	SELL	$36.06 - $69.85 $36,276 - $70,269	-1,006 Reduced 5.8%	16,342 $729,000
Q3 2022 Jun 14, 2023	SELL	$36.06 - $69.85 $20,121 - $38,976	-558 Reduced 3.3%	16,342 $729,000
Q3 2022 Mar 22, 2023	SELL	$36.06 - $69.85 $36,276 - $70,269	-1,006 Reduced 5.8%	16,342 $729,000
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $36,276 - $70,269	-1,006 Reduced 5.8%	16,342 $729,000
Q2 2022 Jun 20, 2023	BUY	$21.74 - $46.75 $9,739 - $20,944	448 Added 2.65%	17,348 $664,000
Q1 2022 May 10, 2024	BUY	$23.7 - $41.39 $411,147 - $718,033	17,348 New	17,348 $718,000
Q1 2022 Jun 20, 2023	BUY	$23.7 - $41.39 $10,617 - $18,542	448 Added 2.65%	17,348 $718,000
Q1 2022 Mar 22, 2023	BUY	$23.7 - $41.39 $152,604 - $266,510	6,439 Added 59.02%	17,348 $718,000
Q1 2022 May 12, 2022	BUY	$23.7 - $41.39 $152,604 - $266,510	6,439 Added 59.02%	17,348 $718,000
Q4 2021 Jun 21, 2023	SELL	$30.7 - $43.36 $183,923 - $259,769	-5,991 Reduced 35.45%	10,909 $412,000
Q3 2021 Jun 21, 2023	SELL	$19.91 - $68.26 $119,280 - $408,945	-5,991 Reduced 35.45%	10,909 $359,000
Q2 2021 Jun 21, 2023	SELL	$50.63 - $73.5 $303,324 - $440,338	-5,991 Reduced 35.45%	10,909 $735,000
Q1 2021 May 17, 2024	SELL	$55.91 - $81.44 $424,580 - $618,455	-7,594 Reduced 41.04%	10,909 $617,000
Q1 2021 Jun 26, 2023	SELL	$55.91 - $81.44 $334,956 - $487,907	-5,991 Reduced 35.45%	10,909 $618 Million
Q4 2020 May 24, 2024	SELL	$66.31 - $86.52 $93,032 - $121,387	-1,403 Reduced 11.4%	10,909 $888,000
Q4 2020 Jun 22, 2023	SELL	$66.31 - $86.52 $397,263 - $518,341	-5,991 Reduced 35.45%	10,909 $888,000
Q4 2020 Mar 22, 2023	SELL	$66.31 - $86.52 $93,032 - $121,387	-1,403 Reduced 11.4%	10,909 $888,000
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $93,032 - $121,387	-1,403 Reduced 11.4%	10,909 $889,000
Q3 2020 Jun 26, 2023	SELL	$68.34 - $85.84 $313,543 - $393,833	-4,588 Reduced 27.15%	12,312 $877,000
Q2 2020 May 24, 2024	SELL	$49.87 - $98.69 $308,745 - $610,989	-6,191 Reduced 33.46%	12,312 $1.01 Billion
Q2 2020 Jun 26, 2023	SELL	$49.87 - $98.69 $228,803 - $452,789	-4,588 Reduced 27.15%	12,312 $1.01 Million
Q2 2020 Mar 22, 2023	BUY	$49.87 - $98.69 $33,911 - $67,109	680 Added 5.85%	12,312 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $33,911 - $67,109	680 Added 5.85%	12,312 $1.01 Million
Q1 2020 Jul 12, 2023	SELL	$41.2 - $101.31 $217,041 - $533,701	-5,268 Reduced 31.17%	11,632 $684,000
Q1 2020 Mar 22, 2023	BUY	$41.2 - $101.31 $39,634 - $97,460	962 Added 9.02%	11,632 $684,000
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $39,634 - $97,460	962 Added 9.02%	11,632 $684,000
Q4 2019 Jul 12, 2023	SELL	$16.71 - $106.24 $104,103 - $661,875	-6,230 Reduced 36.86%	10,670 $1.1 Million
Q4 2019 Mar 22, 2023	SELL	$16.71 - $106.24 $17,161 - $109,108	-1,027 Reduced 8.78%	10,670 $1.1 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $17,161 - $109,108	-1,027 Reduced 8.78%	10,670 $1.1 Million
Q3 2019 Jul 12, 2023	SELL	$20.24 - $29.16 $105,308 - $151,719	-5,203 Reduced 30.79%	11,697 $236,000
Q3 2019 Mar 22, 2023	SELL	$20.24 - $29.16 $105,308 - $151,719	-5,203 Reduced 30.79%	11,697 $236,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $236,747 - $341,084	11,697 New	11,697 $237,000
Q2 2019 Jul 12, 2023	SELL	$13.46 - $25.75 $70,032 - $133,977	-5,203 Reduced 30.79%	11,697 $301 Million

Others Institutions Holding AXSM

# of Institutions

355

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Axsome Therapeutics, Inc. Transaction History